Influence of topical anti-VEGF (Ranibizumab) on the outcome of filtration surgery for glaucoma
Completed
- Conditions
- Glaucoma, patients with excessive wound healing after trabeculectomy.Eye DiseasesGlaucoma
- Registration Number
- ISRCTN12125882
- Lead Sponsor
- Horten Center, University of Zurich (Switzerland)
- Brief Summary
Not available
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- Completed
- Sex
- All
- Target Recruitment
- 50
Inclusion Criteria
1. Patients with primary open angle glaucoma (POAG), PEX and pigment dispersion Glaucoma
2. At least 18 years of age
3. No previous intraocular surgery undergoing trabeculectomy or phaco-trabeculectomy
Exclusion Criteria
1. Patients with primary angle closure glaucoma (PACG)
2. Glaucoma due to other causes
3. Previous intra- and extraocular surgery
4. Any surgery during the last 3 months
5. Patients with uveitis or inflammatory ocular surface disease
6. Patients with single eyes
7. Patients presenting the first postoperative day with bleb leak, hypotony or situations that potentially need another surgery
8. Pregnant and breast feeding women
9. Women planning to get pregnant
Study & Design
- Study Type
- Interventional
- Study Design
- Not specified
- Primary Outcome Measures
Name Time Method
- Secondary Outcome Measures
Name Time Method